Atlanthera Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.95M
- Investors
-
3
Atlanthera General Information
Description
Developer of a drug discovery platform designed to treat bone tumors and metastases. The company's platform offers new chemical molecules based on the vectorization of active pharmaceutical ingredients to bone tissue, enabling doctors to use novel treatments that specifically target bone tumors and are able to locally deliver high concentrations of active molecules and limit systemic adverse effects.
Contact Information
Website
www.atlanthera.comCorporate Office
- 3 rue Aronnax
- Saint-Herblain Cedex
- 44821 Nantes
- France
Corporate Office
- 3 rue Aronnax
- Saint-Herblain Cedex
- 44821 Nantes
- France
Atlanthera Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 24-Nov-2021 | $2.95M | Completed | Generating Revenue | ||
| 3. Later Stage VC | 01-Feb-2017 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 14-Apr-2014 | $1.5M | $1.5M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Atlanthera Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Preference | ||||||||
| Ordinary | 105 | $1.147488 | $3191.39 | $3191.39 | 1x | $3191.39 | 3.62% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Atlanthera Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Atlanthera Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Atlanthera Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Fair West | Accelerator/Incubator | Minority | ||
| GO Capital | Venture Capital | Minority | ||
| Atlanpole | Accelerator/Incubator |
Atlanthera FAQs
-
When was Atlanthera founded?
Atlanthera was founded in 2009.
-
Where is Atlanthera headquartered?
Atlanthera is headquartered in Nantes, France.
-
What is the size of Atlanthera?
Atlanthera has 12 total employees.
-
What industry is Atlanthera in?
Atlanthera’s primary industry is Drug Discovery.
-
Is Atlanthera a private or public company?
Atlanthera is a Private company.
-
What is the current valuation of Atlanthera?
The current valuation of Atlanthera is .
-
What is Atlanthera’s current revenue?
The current revenue for Atlanthera is .
-
How much funding has Atlanthera raised over time?
Atlanthera has raised $8.61M.
-
Who are Atlanthera’s investors?
Fair West, GO Capital, and Atlanpole have invested in Atlanthera.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
